Comments
Loading...

Moderna Analyst Ratings

MRNANASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Hold
Highest Price Target1
$150.00
Lowest Price Target1
$26.00
Consensus Price Target1
$66.64

Moderna Analyst Ratings and Price Targets | NASDAQ:MRNA | Benzinga

Moderna Inc has a consensus price target of $66.64 based on the ratings of 27 analysts. The high is $150 issued by Cowen & Co. on January 25, 2023. The low is $26 issued by JP Morgan on May 22, 2025. The 3 most-recent analyst ratings were released by JP Morgan, UBS, and Barclays on May 22, 2025, May 2, 2025, and May 2, 2025, respectively. With an average price target of $45.33 between JP Morgan, UBS, and Barclays, there's an implied 71.78% upside for Moderna Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
1
1
Feb
1
1
Mar
1
Apr
1
1
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
1.8
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

JP Morgan
UBS
Barclays
RBC Capital
Evercore ISI Group

1calculated from analyst ratings

Analyst Ratings for Moderna

Buy NowGet Alert
05/22/2025Buy Now-1.48%JP Morgan
Jessica Fye64%
$33 → $26MaintainsUnderweightGet Alert
05/02/2025Buy Now165.25%UBS
Eliana Merle43%
$78 → $70MaintainsBuyGet Alert
05/02/2025Buy Now51.57%Barclays
Gena Wang50%
$45 → $40MaintainsEqual-WeightGet Alert
05/02/2025Buy Now6.1%RBC Capital
Luca Issi42%
$32 → $28MaintainsSector PerformGet Alert
05/02/2025Buy Now21.26%Evercore ISI Group
Cory Kasimov68%
$50 → $32MaintainsIn-LineGet Alert
04/09/2025Buy Now21.26%Morgan Stanley
Matthew Harrison61%
$39 → $32MaintainsEqual-WeightGet Alert
03/21/2025Buy Now25.05%JP Morgan
Jessica Fye64%
$40 → $33MaintainsUnderweightGet Alert
03/13/2025Buy Now51.57%Citigroup
Geoff Meacham61%
→ $40Initiates → NeutralGet Alert
02/19/2025Buy Now195.57%UBS
Eliana Merle43%
$96 → $78MaintainsBuyGet Alert
02/18/2025Buy Now51.57%RBC Capital
Luca Issi42%
$40 → $40ReiteratesSector Perform → Sector PerformGet Alert
02/18/2025Buy Now70.52%Barclays
Gena Wang50%
$111 → $45DowngradeOverweight → Equal-WeightGet Alert
02/11/2025Buy Now28.84%B of A Securities
Tim Anderson59%
$41 → $34MaintainsUnderperformGet Alert
01/29/2025Buy Now93.26%Goldman Sachs
Salveen Richter53%
$99 → $51DowngradeBuy → NeutralGet Alert
01/28/2025Buy Now275.14%Goldman Sachs
Salveen Richter53%
$112 → $99MaintainsBuyGet Alert
01/27/2025Buy Now89.47%Evercore ISI Group
Cory Kasimov68%
$60 → $50MaintainsIn-LineGet Alert
01/15/2025Buy Now43.99%Morgan Stanley
Matthew Harrison61%
$70 → $38MaintainsEqual-WeightGet Alert
01/08/2025Buy Now263.77%UBS
Eliana Merle43%
$108 → $96MaintainsBuyGet Alert
12/18/2024Buy NowArgus Research
John Eade74%
DowngradeBuy → HoldGet Alert
12/10/2024Buy Now55.36%B of A Securities
Tim Anderson59%
→ $41Reinstates → UnderperformGet Alert
11/26/2024Buy Now70.52%JP Morgan
Jessica Fye64%
$59 → $45MaintainsUnderweightGet Alert
11/18/2024Buy Now161.46%Piper Sandler
Edward Tenthoff50%
$115 → $69ReiteratesOverweight → OverweightGet Alert
11/18/2024Buy Now119.78%HSBC
Yifeng Liu34%
→ $58UpgradeHold → BuyGet Alert
11/15/2024Buy Now51.57%Wolfe Research
Alexandria Hammond44%
→ $40Initiates → UnderperformGet Alert
11/08/2024Buy Now320.61%Barclays
Gena Wang50%
$125 → $111MaintainsOverweightGet Alert
11/08/2024Buy NowNeedham
Joseph Stringer55%
Reiterates → HoldGet Alert
11/04/2024Buy Now123.57%JP Morgan
Jessica Fye64%
$70 → $59MaintainsUnderweightGet Alert
10/24/2024Buy Now309.25%UBS
Eliana Merle43%
$140 → $108MaintainsBuyGet Alert
10/17/2024Buy Now108.41%Bernstein
Courtney Breen1%
→ $55Initiates → Market PerformGet Alert
10/15/2024Buy Now108.41%Jefferies
Michael Yee55%
$65 → $55MaintainsHoldGet Alert
09/19/2024Buy Now184.2%RBC Capital
Luca Issi42%
$75 → $75ReiteratesSector Perform → Sector PerformGet Alert
09/16/2024Buy Now426.71%Goldman Sachs
Salveen Richter53%
$178 → $139MaintainsBuyGet Alert
09/16/2024Buy Now373.66%Barclays
Gena Wang50%
$155 → $125MaintainsOverweightGet Alert
09/13/2024Buy Now316.82%B of A Securities
Geoff Meacham61%
$130 → $110MaintainsNeutralGet Alert
09/13/2024Buy Now335.77%Piper Sandler
Edward Tenthoff50%
$157 → $115MaintainsOverweightGet Alert
09/13/2024Buy Now127.36%TD Cowen
Tyler Van Buren44%
$70 → $60MaintainsHoldGet Alert
09/13/2024Buy Now184.2%RBC Capital
Luca Issi42%
$90 → $75MaintainsSector PerformGet Alert
09/13/2024Buy Now165.25%JP Morgan
Jessica Fye64%
$88 → $70DowngradeNeutral → UnderweightGet Alert
09/13/2024Buy Now146.31%Jefferies
Michael Yee55%
$120 → $65DowngradeBuy → HoldGet Alert
09/13/2024Buy NowOppenheimer
Hartaj Singh46%
DowngradeOutperform → PerformGet Alert
09/13/2024Buy NowNeedham
Joseph Stringer55%
Reiterates → HoldGet Alert
08/28/2024Buy Now210.72%HSBC
Yifeng Liu34%
→ $82UpgradeReduce → HoldGet Alert
08/15/2024Buy Now233.46%JP Morgan
Jessica Fye64%
$96 → $88MaintainsNeutralGet Alert
08/06/2024Buy Now203.15%Deutsche Bank
Emmanuel Papadakis47%
$85 → $80UpgradeSell → HoldGet Alert
08/05/2024Buy Now241.04%RBC Capital
Luca Issi42%
$125 → $90DowngradeOutperform → Sector PerformGet Alert
08/02/2024Buy Now373.66%RBC Capital
Luca Issi42%
$160 → $125MaintainsOutperformGet Alert
08/02/2024Buy Now574.5%Goldman Sachs
Salveen Richter53%
$204 → $178MaintainsBuyGet Alert
08/02/2024Buy Now487.34%Barclays
Gena Wang50%
$168 → $155MaintainsOverweightGet Alert
08/02/2024Buy Now494.92%Piper Sandler
Edward Tenthoff50%
$214 → $157ReiteratesOverweight → OverweightGet Alert
08/01/2024Buy NowNeedham
Joseph Stringer55%
Reiterates → HoldGet Alert
06/28/2024Buy NowNeedham
Joseph Stringer55%
Reiterates → HoldGet Alert
06/27/2024Buy Now710.91%Piper Sandler
Edward Tenthoff50%
$214 → $214ReiteratesOverweight → OverweightGet Alert
06/27/2024Buy Now354.72%Evercore ISI Group
Cory Kasimov68%
$120 → $120MaintainsIn-LineGet Alert
06/12/2024Buy Now263.77%JP Morgan
Jessica Fye64%
$85 → $96MaintainsNeutralGet Alert
06/12/2024Buy Now578.29%Oppenheimer
Hartaj Singh46%
$163 → $179MaintainsOutperformGet Alert
06/03/2024Buy Now506.29%RBC Capital
Luca Issi42%
$135 → $160MaintainsOutperformGet Alert
06/03/2024Buy NowNeedham
Joseph Stringer55%
Reiterates → HoldGet Alert
05/14/2024Buy Now354.72%Evercore ISI Group
Cory Kasimov68%
→ $120Initiates → In-LineGet Alert
05/07/2024Buy Now472.19%UBS
Eliana Merle43%
$143 → $151MaintainsBuyGet Alert
05/03/2024Buy Now301.67%Canaccord Genuity
Bill Maughan19%
$91 → $106MaintainsHoldGet Alert
05/03/2024Buy Now411.56%RBC Capital
Luca Issi42%
$125 → $135MaintainsOutperformGet Alert
05/03/2024Buy Now517.66%Oppenheimer
Hartaj Singh46%
$142 → $163MaintainsOutperformGet Alert
05/02/2024Buy NowNeedham
Joseph Stringer55%
Reiterates → HoldGet Alert
04/11/2024Buy NowNeedham
Joseph Stringer55%
Reiterates → HoldGet Alert
04/09/2024Buy Now373.66%Jefferies
Michael Yee55%
→ $125ReiteratesBuy → BuyGet Alert
03/28/2024Buy Now373.66%RBC Capital
Luca Issi42%
$125 → $125ReiteratesOutperform → OutperformGet Alert
03/28/2024Buy NowNeedham
Joseph Stringer55%
Reiterates → HoldGet Alert
03/15/2024Buy Now222.09%JP Morgan
Jessica Fye64%
$90 → $85MaintainsNeutralGet Alert
02/26/2024Buy Now225.88%HSBC
Yifeng Liu34%
$75 → $86DowngradeHold → ReduceGet Alert
02/23/2024Buy Now373.66%RBC Capital
Luca Issi42%
$125 → $125ReiteratesOutperform → OutperformGet Alert
02/23/2024Buy Now244.83%Canaccord Genuity
Bill Maughan19%
$82 → $91MaintainsHoldGet Alert
01/12/2024Buy Now373.66%RBC Capital
Luca Issi42%
$125 → $125ReiteratesOutperform → OutperformGet Alert
01/02/2024Buy Now438.08%Oppenheimer
Hartaj Singh46%
→ $142UpgradePerform → OutperformGet Alert
12/01/2023Buy Now241.04%JP Morgan
Jessica Fye64%
$93 → $90MaintainsNeutralGet Alert
11/29/2023Buy Now210.72%Canaccord Genuity
Bill Maughan19%
→ $82Initiates → HoldGet Alert
11/03/2023Buy Now373.66%RBC Capital
Luca Issi42%
$180 → $125MaintainsOutperformGet Alert
11/03/2023Buy Now775.33%Goldman Sachs
Salveen Richter53%
$269 → $231MaintainsBuyGet Alert
11/03/2023Buy Now161.46%HSBC
Yifeng Liu34%
$89 → $69UpgradeReduce → HoldGet Alert
11/02/2023Buy NowDeutsche Bank
Emmanuel Papadakis47%
DowngradeHold → SellGet Alert
09/13/2023Buy Now430.5%Argus Research
Jasper Hellweg69%
$160 → $140MaintainsBuyGet Alert
08/04/2023Buy Now366.09%Morgan Stanley
Matthew Harrison61%
$128 → $123MaintainsEqual-WeightGet Alert
08/04/2023Buy Now468.4%B of A Securities
Geoff Meacham61%
$175 → $150MaintainsNeutralGet Alert
08/04/2023Buy Now619.97%RBC Capital
Luca Issi42%
$200 → $190MaintainsOutperformGet Alert
08/04/2023Buy Now373.66%TD Cowen
Tyler Van Buren44%
$145 → $125DowngradeOutperform → Market PerformGet Alert
08/03/2023Buy Now373.66%Deutsche Bank
Emmanuel Papadakis47%
$200 → $125DowngradeBuy → HoldGet Alert
07/24/2023Buy Now525.24%TD Cowen
Tyler Van Buren44%
$175 → $165MaintainsOutperformGet Alert
07/24/2023Buy NowWilliam Blair
Myles Minter38%
Initiates → Market PerformGet Alert
07/14/2023Buy Now267.56%HSBC
Rajesh Kumar61%
→ $97Initiates → ReduceGet Alert
07/11/2023Buy Now385.03%Morgan Stanley
Matthew Harrison61%
$153 → $128MaintainsEqual-WeightGet Alert
06/26/2023Buy Now623.76%UBS
Eliana Merle43%
$221 → $191UpgradeNeutral → BuyGet Alert
05/05/2023Buy Now631.34%Morgan Stanley
Matthew Harrison61%
$185 → $193MaintainsEqual-WeightGet Alert
04/26/2023Buy NowGuggenheim
Evan Wang8%
Initiates → NeutralGet Alert
04/12/2023Buy Now430.5%JP Morgan
Jessica Fye64%
$145 → $140MaintainsNeutralGet Alert
04/10/2023Buy Now449.45%JP Morgan
Jessica Fye64%
$127 → $145MaintainsNeutralGet Alert
03/13/2023Buy Now582.08%TD Cowen
Tyler Van Buren44%
$150 → $180UpgradeMarket Perform → OutperformGet Alert
03/02/2023Buy Now657.86%RBC Capital
Luca Issi42%
→ $200Initiates → OutperformGet Alert
02/28/2023Buy Now657.86%Deutsche Bank
Emmanuel Papadakis47%
$225 → $200MaintainsBuyGet Alert
02/24/2023Buy Now252.41%SVB Leerink
Mani Foroohar47%
$111 → $93DowngradeMarket Perform → UnderperformGet Alert
02/08/2023Buy Now422.93%JP Morgan
Jessica Fye64%
$132 → $138MaintainsNeutralGet Alert
01/25/2023Buy Now468.4%Cowen & Co.
Tyler Van Buren44%
$130 → $150MaintainsMarket PerformGet Alert
01/24/2023Buy Now676.81%Morgan Stanley
Matthew Harrison61%
$209 → $205MaintainsEqual-WeightGet Alert

FAQ

Q

What is the target price for Moderna (MRNA) stock?

A

The latest price target for Moderna (NASDAQ:MRNA) was reported by JP Morgan on May 22, 2025. The analyst firm set a price target for $26.00 expecting MRNA to fall to within 12 months (a possible -1.48% downside). 56 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Moderna (MRNA)?

A

The latest analyst rating for Moderna (NASDAQ:MRNA) was provided by JP Morgan, and Moderna maintained their underweight rating.

Q

When was the last upgrade for Moderna (MRNA)?

A

The last upgrade for Moderna Inc happened on November 18, 2024 when HSBC raised their price target to $58. HSBC previously had a hold for Moderna Inc.

Q

When was the last downgrade for Moderna (MRNA)?

A

The last downgrade for Moderna Inc happened on February 18, 2025 when Barclays changed their price target from $111 to $45 for Moderna Inc.

Q

When is the next analyst rating going to be posted or updated for Moderna (MRNA)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moderna, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moderna was filed on May 22, 2025 so you should expect the next rating to be made available sometime around May 22, 2026.

Q

Is the Analyst Rating Moderna (MRNA) correct?

A

While ratings are subjective and will change, the latest Moderna (MRNA) rating was a maintained with a price target of $33.00 to $26.00. The current price Moderna (MRNA) is trading at is $26.39, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch